Search research articles
Contact Us
Filters
Showing results (1-10 of 128) with videos related to
Page
of 13
Sort By:
Breast Disease
|
October 6, 2007
Breast cancer risk assessment and genetic testing: complexities, conundrums, and community
Beth N Peshkin
Oncology (Williston Park, N.Y.)
|
December 24, 2005
Evaluation and management of women with BRCA1/2 mutations
Beth N Peshkin, Claudine Isaacs
The New England Journal of Medicine
|
October 1, 2015
ClinGen and Genetic Testing
Beth N Peshkin, Claudine Isaacs
Oncology (Williston Park, N.Y.)
|
September 6, 2014
Genetic testing: the bigger picture
Beth N Peshkin, Tiffani A Demarco
Breast Disease
|
July 23, 2011
BRCA1/2 mutations and triple negative breast cancers
Beth N Peshkin, Michelle L Alabek, Claudine Isaacs
Journal of the National Cancer Institute
|
March 7, 2019
Re: Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative
Beth N Peshkin, Claudine Isaacs, Marc D Schwartz
Familial Cancer
|
July 18, 2009
On the development of a decision support intervention for mothers undergoing BRCA1/2 cancer genetic testing regarding communicating test results to their children
Beth N Peshkin, Tiffani A Demarco, Kenneth P Tercyak
The New England Journal of Medicine
|
October 2, 2002
Oophorectomy in carriers of BRCA mutations
Beth N Peshkin, Tiffani A DeMarco, Marc D Schwartz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2007
Genetic counseling about reproductive options for hereditary cancer: what is the standard of care?
Beth N Peshkin, Rachel H Nusbaum, Tiffani A DeMarco
Inquiry : a Journal of Medical Care Organization, Provision and Financing
|
November 28, 2007
Genetic discrimination in health insurance: current legal protections and industry practices
Karen Pollitz, Beth N Peshkin, Eliza Bangit, et al.
Page
of 13
Search research articles
Search
Showing results (1-10 of 128) with videos related to
Sort By:
Page
of 13
Breast Disease
|
October 6, 2007
Breast cancer risk assessment and genetic testing: complexities, conundrums, and community
Beth N Peshkin
Oncology (Williston Park, N.Y.)
|
December 24, 2005
Evaluation and management of women with BRCA1/2 mutations
Beth N Peshkin, Claudine Isaacs
The New England Journal of Medicine
|
October 1, 2015
ClinGen and Genetic Testing
Beth N Peshkin, Claudine Isaacs
Oncology (Williston Park, N.Y.)
|
September 6, 2014
Genetic testing: the bigger picture
Beth N Peshkin, Tiffani A Demarco
Breast Disease
|
July 23, 2011
BRCA1/2 mutations and triple negative breast cancers
Beth N Peshkin, Michelle L Alabek, Claudine Isaacs
Journal of the National Cancer Institute
|
March 7, 2019
Re: Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative
Beth N Peshkin, Claudine Isaacs, Marc D Schwartz
Familial Cancer
|
July 18, 2009
On the development of a decision support intervention for mothers undergoing BRCA1/2 cancer genetic testing regarding communicating test results to their children
Beth N Peshkin, Tiffani A Demarco, Kenneth P Tercyak
The New England Journal of Medicine
|
October 2, 2002
Oophorectomy in carriers of BRCA mutations
Beth N Peshkin, Tiffani A DeMarco, Marc D Schwartz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2007
Genetic counseling about reproductive options for hereditary cancer: what is the standard of care?
Beth N Peshkin, Rachel H Nusbaum, Tiffani A DeMarco
Inquiry : a Journal of Medical Care Organization, Provision and Financing
|
November 28, 2007
Genetic discrimination in health insurance: current legal protections and industry practices
Karen Pollitz, Beth N Peshkin, Eliza Bangit, et al.
Page
of 13